Skip to content

Clinical trials

Observational Myeloproliferative Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Country / region: Canada Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20152
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Icahn School of Medicine at Mount Sinai1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders4
Neoplasms2
Polycythemia Vera2
Primary Myelofibrosis2
Thrombocythemia, Essential2
Bone Marrow Diseases1
Carcinoma in Situ1
Central Nervous System Neoplasms1
Desmoid Tumors1
Ganglioneuroma1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.